Comparative Effectiveness Funding In Stimulus Bill Raises Some Red Flags

Industry observers see red flags in how House Democrats have structured the language related to comparative effectiveness in the economic stimulus bill, with questions on how the money will be spent as well as its potential to leave the door open for cost-effectiveness comparisons of medical products